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Abstract
Background: Archival formalin-fixed paraffin-embedded (FFPE) tissues represent an abundant
source of clinical specimens; however their use is limited in applications involving analysis of gene
expression due to RNA degradation and modification during fixation and processing. This study
improved the quality of RNA extracted from FFPE by introducing a heating step into the selected
extraction protocols. Further, it evaluated a novel pre-amplification system (PreAmp) designed to
enhance expression analysis from tissue samples using assays with a range of amplicon size (62–164
bp).
Results: Results from the Bioanalyzer and TaqMan® data showed improvement of RNA quality
extracted using the modified protocols from FFPE. Incubation at 70°C for 20 minutes was
determined to be the best condition of those tested to disrupt cross-links while not compromising
RNA integrity. TaqMan®  detection was influenced by master mix, amplicon size and the
incorporation of a pre-amplification step. TaqMan® PreAmp consistently achieved decreased CT
values in both snap frozen and FFPE aliquots compared with no pre-amplification.
Conclusion: Modification to extraction protocols has facilitated procurement of RNA that may
be successfully amplified using QRT-PCR. TaqMan® PreAmp system is a robust and practical
solution to limited quantities of RNA from FFPE extracts.
Background
Archival Formalin-Fixed, Paraffin-Embedded (FFPE) tis-
sue samples represent a robust and invaluable source of
human tissue for gene expression analysis. Compared to
fresh and snap frozen tissue, FFPE tissue has an inherent
advantage in that retrospective patient data, including sur-
vival history and treatment response etc, is readily availa-
ble, allowing immediate comparison with clinical
pathological parameters. Data generated can potentially
highlight biomarkers useful in disease classification, diag-
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nosis and prognosis, and potentially elucidate novel ther-
apeutic targets [1,2].
However, these tissues have not been widely used in
molecular biology due to the degradation and chemical
modification of RNA extracted from FFPE blocks. RNA
extracted from FFPE is degraded to fewer than 300 bases
[3] in length because archived blocks are often stored at
room temperature for long periods of time. The situation
is made more complicated by the fact that RNA is modi-
fied by methylol groups to form cross-links with protein
or nucleic acid during formalin fixation [4-6], which
results in poor yields [1,7] and compromised extracts.
Real-time quantitative TaqMan®  reverse transcriptase-
polymerase chain reaction (QRT-PCR) analysis has been
introduced as a sensitive, accurate, and highly reproduci-
ble method to study gene expression [8]. It has been suc-
cessfully used to detect gene transcript levels from snap
frozen tissue extracts and even from FFPE containing par-
tially fragmented RNA [9-11] although the detection rate
is lower as indicated for example by invariably higher CT
values in the latter [12-16].
In this study we examined and optimized selected RNA
extraction protocols, including Stratagene Absolutely
RNA® FFPE Kit and Ambion RecoverAll™ Total Nucleic
Acid Isolation Kit, by comparison of parallel extracts from
FFPE and snap frozen cell preparations using a cell line
model (Figure 1). We further analyzed these extracts using
different TaqMan® protocols, including two types of Taq-
Man® Master Mix (Universal PCR Master Mix (UPMM)
and Gene Expression Master Mix (GEMM)) and newly
developed TaqMan®  with pre-amplification method




RNA quantity was assessed spectrophotometrically using
NanoDrop® ND-1000 Spectrophotometer (Wilmington,
USA), which showed that the yields from snap frozen
extracts were greater than those from FFPE when RNA was
extracted from identical numbers of cells using all the pro-
tocols examined (Stratagene Absolutely RNA® FFPE Kit,
Ambion RecoverAll™ Total Nucleic Acid Isolation Kit,
Gentra Purescript® RNA Purification Kit and Invitrogen
Trizol® Reagent). In comparison of FFPE extracts (Table 1),
Ambion gave the highest yields, and column based Strat-
agene and Ambion protocols produced clean RNA with
OD 260/280 ratio greater than 1.8. RNA quality was
assessed using Agilent 2100 Bioanalyzer (Agilent technol-
ogies, Waldbronn, Germany) and TaqMan®  RT-PCR,
which showed variations in RNA quality dependant on
the protocol used. Stratagene and Ambion RecoverAll™
kits gave superior FFPE RNA results with regard to quality
than the others examined.
Evaluation of modified protocols
Modification to the Stratagene and Ambion protocols
generated approximately 25–40% greater yields and larger
fragments of RNA (Figure 2) than the standard procedure.
Adjustment to Stratagene and Ambion protocols pro-
duced decreased CTs (e.g. with a mean of 2.95 cycles in
GEMM experiment and a mean of 3.14 cycles in PreAmp),
indicating the improved quality of RNA extracted from
FFPE (Figure 3).
A separate experiment using Ambion RecoverAll™ kit ena-
bled extraction of large RNA molecules including cross-
linked RNAs (Figure 4). Incubation of eluted RNA at 70°C
Table 1: RNA yields from FFPE materials. Extraction products 
were assessed spectrophotometrically using NanoDrop® ND-
1000 Spectrophotometer. Three extractions were carried out 
using each protocol.
OD Ratio (260/280) Yields (ng)
Ambion 2.1 +/- 0.1 337 +/- 58
Stratagene 2.1 +/- 0.1 147 +/- 26
Gentra 1.6 +/- 0.1 186 +/- 67
Trizol 1.6 +/- 0.1 108 +/- 72
A schematic representation of the experimental procedures Figure 1
A schematic representation of the experimental pro-
cedures. Normal thyroid cell lines were split into two aliq-
uots: One was snap frozen, the other formalin fixed and 
paraffin embedded. RNA was extracted using selected proto-
cols and was then reverse transcribed into cDNA followed 
by different TaqMan® QRT-PCR analysis.BMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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for 20 minutes was found to be the best condition to dis-
rupt cross-links while not compromising RNA integrity in
comparison with other modifications (70°C for 10 min,
95°C for 10 min and 95°C for 20 min).
Comparison of TaqMan® Universal PCR Master Mix 
(UPMM), Gene Expression Master Mix (GEMM) and 
PreAmp
CT values were also dependent on the type of TaqMan®
PCR Master Mix that was used (Figure 3 and Figure 5).
TaqMan®  with UPMM generated higher CTs for long
amplicons than GEMM. This was observed by a compari-
son of two GAPDH assays – one 122 bp and the other 67
bp. There was a mean threshold detection difference of 17
cycles using UPMM and a mean difference of 4 cycles
using GEMM with RNA template extracted using Ambion
RecoverAll™ kit (Figure 3). In addition, HLA_A is the larg-
est amplicon (164 bp) which produced no product with
UPMM, however, GEMM and PreAmp both allowed the
detection of this amplicon size (Figure 3). GEMM
improved the CT values for long amplicons (over 100 bp)
compared with UPMM (Figure 5-a). When the ΔCTs were
compared to Theoretical ΔCTs, PreAmp results generally
correlated with GEMM for all the 8 assays analyzed (Fig-
ure 5-c).
Evaluation of TaqMan® PreAmp using CDKN1B
TaqMan®  PreAmp analysis consistently achieved
decreased CT values in both snap frozen and FFPE aliquots
compared with TaqMan® without pre-amplification step
(Figure 5-b, c). A good correlation between PreAmp and
UPMM was observed using CDKN1B to analyze RNA
extracted with different protocols (Figure 6), suggesting
that PreAmp does not introduce any bias into the reac-
tion.
Comparison of CT difference between FFPE and snap 
frozen cells
TaqMan® analysis over all assays showed CTs to be 2 to 11
cycles higher when using FFPE extracts compared to snap
frozen counterparts when the amounts of input RNA were
identical (Figure 3). Focussing on an analysis of GAPDH
using two assays with different amplicon sizes revealed
the smaller amplicon assay (67 bp) produced CTs from
snap frozen and FFPE samples that were closer together
(Figure 7).
Qualities of RNA were measured using Agilent 2100 Bioanalyzer Figure 2
Qualities of RNA were measured using Agilent 2100 Bioanalyzer. (Str = Stratagene protocol; Am = Ambion protocol; 
+ = modified with incubation in Proteinase K buffer at 70°C for 20 minutes; and SN = snap frozen.) Modification to the Strata-
gene and Ambion protocols generated larger fragments (lane 2 and 5) compared to the extracts generated using the original 
protocols (lane 1 and 4). Each well contained 1 μl of extracted RNA from equal amount of starting materials of 105 cells.BMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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Discussion
RNA analysis has generally been performed on snap-fro-
zen or fresh materials, using variable techniques including
microarray, northern blotting and RT-PCR. However, a
constant challenge has been robust and reliable analysis
of gene expression in archival tissues. This application has
been frustrated by poor RNA yields, small sizes of
extracted fragments and low levels of detectable RNA in
the extracts [12]. In this study we established a cell line
model to test modified extraction protocols and quantify
differences in performance using a panel of QRT-PCR
assays on FFPE compared with parallel snap-frozen cell
preparations using TaqMan® methodology. We found that
our modified extraction method and TaqMan® PreAmp
enhanced expression analysis from FFPE cells optimally.
RNA and FFPE
Generally, RNA extracted from FFPE materials is frag-
mented and chemically modified. Fragmentation occurs
possibly since tissues are surgically removed, and it con-
tinuously occurs during fixation and preservation. Experi-
mental design was such that equal numbers of cells were
processed for FFPE cell block construction and snap freez-
ing for comparative purposes. By using cells fixed under
controlled conditions possible variables due to the effects
of storage on RNA degradation were negated, thus reveal-
ing the true impact of formalin fixation on RNA quality.
We extracted intact RNA fragments in a separate experi-
ment from pellets with a large number of formalin fixed
paraffin embedded normal thyroid cells (Figure 4), which
was consistent with a finding by Scicchitana et al [17]. In
that study, intact RNA molecules were extracted from
newly formalin fixed paraffin embedded human bone
marrow stromal cells suggesting that RNA degradation
could be a minor problem for recently fixed FFPE in some
types of cells. Our study showed that the differences in
RNA quality between the small and large fixed pellets (Fig-
ure 2 and Figure 4) might be due to the fact that the major-
ity of cells in the centre of the large pellet were remained
alive during construction of the large solid cell pellet. This
could limit the access of RNases to intracellular mRNA
because degradation will not fully occur until the fixation
process begins resulting to the intact mRNA being main-
tained. Unfortunately, intact mRNA is not generally
obtained in majority of fixed tissues or cell lines, and RNA
extracted from FFPE is normally degraded to fewer than
300 bp.
TaqMan® gene expression pattern using UPMM, GEMM and PreAmp Figure 3
TaqMan® gene expression pattern using UPMM, GEMM and PreAmp. (Str = Stratagene protocol; Am = Ambion pro-
tocol; + = modified protocols with incubation in Proteinase K buffer at 70°C for 20 minutes; and SN = snap frozen cells. Not 
all assays produced products, e.g. HLA_A in UPMM.) CTs were higher using FFPE extracts compared to snap frozen counter-
parts when the amount of input RNA was identical. Modification to Stratagene and Ambion protocols produced decreased 
CTs. TaqMan® with UPMM generated higher CTs than GEMM and PreAmp when using longer amplicon lengths. This was partic-
ularly evident when comparing two GAPDH assays – one 122 bp and the other 67 bp. A mean difference of 17 cycles between 
small and large assays using UPMM and a mean difference of 4 cycles between small and large assays using GEMM was 
observed.BMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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Figure 4 displays the degree of RNA modification in FFPE
cells caused by methylol groups during formalin fixation.
Masuda and colleagues [18] suggested that formaldehyde
reacts with RNA forming an N-methylol followed by an
electrophilic attack to form a methylene bridge between
amino groups. Interestingly, our results show a clear large
RNA band, approximately 5 kb in length (Figure 4-lane
6), which is hypothetically the cross-linked RNA. The
other two bands visualized were also larger than that
extracted from snap frozen cells indicating the modifica-
tion of RNA in FFPE. Furthermore, with incubation at
high temperature, the large RNA band (~5 kb) was
removed, and the sizes of the other two bands became
closer to 18 s and 28 s of the snap frozen extracts. This is
in agreement with the results of a mass spectrometric anal-
ysis that was carried out by Masuda group, suggesting
methylol modification is reversible by heating [18,19].
However, a balance must be achieved between breaking
cross-links while not contributing to degradation of labile
RNA. Our results showed that incubation at 70°C for 20
minutes was the optimal condition, among those tested,
to de-modify cross-linked RNA while maintaining RNA
integrity (Figure 4).
Extraction protocols
A prerequisite for gene expression studies in formalin-
fixed tissue samples was the establishment of a reliable
and reproducible extraction method to provide detectable
RNAs for subsequent analysis [1]. The quality of extracted
RNA can be variable among different extraction methods
The effect of different incubation conditions on RNA Figure 4
The effect of different incubation conditions on RNA. Total RNA was extracted from a large number (2 × 106 cells) of 
formalin fixed paraffin embedded cells using Ambion RecoverAll™ kit. Five eluted RNA aliquots from one extraction were sub-
jected to different incubation conditions on a hot rack (lanes 6 to 10). In parallel, five eluted RNA aliquots from one snap fro-
zen extraction were incubated (lane 1 to 5). Each well contained 1 μl of 4 ng/μl RNA in Ambion Elution Solution. Incubation 
conditions were as follows: 0 = no treatment; 70-10 = 70°C for 10 min; 70-20 = 70°C for 20 min; 95-10 = 95°C for 10 min and 
95-20 = 95°C for 20 min. RNA from snap frozen preparations was not degraded at 70°C for 20 min (lane 3), but was degraded 
at 95°C (lane 4 and 5). RNA from FFPE showed large fragments and cross-linked RNAs which are approximately 5 kb (lane 6 – 
arrow). It was found that incubation of eluted RNA at 70°C for 20 min is the optimal condition, among these tested, to break 
up cross-links while not compromising RNA integrity.BMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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Comparison of TaqMan® gene expression pattern using ΔCT method Figure 5
Comparison of TaqMan® gene expression pattern using ΔCT method. (Am = Ambion protocol; FP = FFPE cells; + = 
modified protocols with incubation in Proteinase K buffer at 70°C for 20 minutes; and SN = snap frozen cells. Not all assays 
produced products, e.g. HLA_A in UPMM.) These ΔCT data was generated from the CTs shown in Figure 3. A Theoretical ΔCT 
was calculated for each chart based on equilibrating the results for any variation in input cDNA. In panel a, ΔCT = CT_UPMM - 
CT_GEMM. The Theoretical ΔCT of UPMM-GEMM was 0 [= Log2(20 ng/20 ng)] given identical input quantities (20 ng) were 
used in each system. In panel b, ΔCT = CT_UPMM - CT_PreAmp. In panel c, ΔCT = CT_GEMM - CT_PreAmp. The Theoretical 
ΔCT in panel b and c was 5.68 [= Log2(1024 ng/20 ng)], which was calculated based on an input of 1024 ng of cDNA for the 
TaqMan® real time PCR component of pre-amplification process. This quantity was generated from an initial 1 ng subjected to 
10 cycles of pre-amplification with a 100% efficiency and no bias introduced from the PreAmp. The relevant Theoretical ΔCT is 
plotted on each chart as a reference point for measuring the actual detected ΔCT against the theoretically optimal ΔCT. The 
benefit of GEMM over UPMM was evident as amplicon size increased (Panel a). A comparison of UPMM and PreAmp showed a 
similar pattern (Panel b). However, PreAmp results generally correlated with GEMM regardless of amplicon size for the series 
of 8 assays analysed (Panel c).BMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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due to several factors, such as the contamination of
RNases, proteins and genomic DNA [20]. Our results
showed that proteinase K digestion based protocols fol-
lowed by on column DNase digestion and RNA elution
produced good detectable RNA of FFPE.
Proteinase K digestion has also been demonstrated by
many laboratories to be critical in RNA extraction proto-
col [1,3,21,22] possibly because of two functions. On one
hand, it can degrade proteins that are covalently cross-
linked with each other and nucleic acid to release RNA
from the matrix, thereby allowing efficient RNA extraction
from FFPE materials [21]. On the other, it can inactivate
RNases that tend to be stable and do not require cofactors
to function. Thus its activity avoids any potential reactiva-
tion of RNase during reversal of fixation in aqueous buff-
ers [1].
Our data demonstrates that incubation in proteinase K
buffer at 70°C for 20 minutes facilitated the disruption of
cross-links, resulting in improved quantity and quality of
RNA. The RNA extracted using the modified protocols
(with the incubation) enhanced detection by a mean of 3
cycles (Figure 3), which is equivalent to 8 fold increased
sensitivity. It is most likely that the additional incubation
step removed the remaining cross-links between RNA and
protein leading to the longer RNA molecules being
extracted [23]. In addition, this incubation denatured pro-
teinase K, thus avoided its further damage to RNA in the
following purification procedure, which suggests the
necessity of a heating (at 70°C for 20 min) application in
any proteinase K based extraction of FFPE samples.
TaqMan® PreAmp
TaqMan® QRT-PCR technique is based on the 5' nuclease
activity of Taq DNA polymerase and involves cleavage of
a specific fluorogenic hybridization probe that is flanked
by PCR primers [24,25]. Because of the small target size,
many laboratories have demonstrated that it is possible to
measure gene expression levels using FFPE tissues as a
source of mRNA [3]. Still, it seems to be problematic to
perform large scale of analysis on FFPE because of the
high CTs and limited concentration of extracts [14,15].
We employed a novel TaqMan® PreAmp technique which
we found to be a practical solution to decrease CT values,
and in particular suitable in our hands to generate real-
time PCR results from limited amounts of input RNA,
such as extracted from laser captured microdissected
material [26]. The principle of TaqMan® PreAmp tech-
nique is to amplify target cDNA prior to real-time Taq-
Man® PCR analysis. Briefly, cDNA is synthesized from
total RNA by use of random priming. The cDNA for the
specific target assays is then amplified by pre-amplifica-
tion reaction using pooled gene-specific primers to
increase the number of targeted copies. The pre-amplifica-
tion product is diluted and finally analyzed by real-time
TaqMan® PCR using single assay containing one pair of
gene-specific primers and probe.
Analysis of GAPDH using two sizes of amplicon showing the  difference of CTs between FFPE and snap frozen counter- parts Figure 7
Analysis of GAPDH using two sizes of amplicon 
showing the difference of CTs between FFPE and 
snap frozen counterparts. ΔCT = CT (FFPE) - CT (Snap-
Frozen). The smaller amplicon size of GAPDH (67 bp) gener-
ated lower ΔCTs than the larger amplicon size of 122 bp indi-
cating that smaller amplicon sizes produced more 
comparable CTs in snap frozen and FFPE samples.
Comparison of TaqMan® real time PCR with or without  PreAmp using CDKN1B assay on extracts produced by dif- ferent extraction protocols Figure 6
Comparison of TaqMan® real time PCR with or with-
out PreAmp using CDKN1B assay on extracts pro-
duced by different extraction protocols. (1 and 2 = 
Stratagene extracts; 3 and 4 = Ambion extracts; 5 and 6 = 
Gentra extracts; 7 and 8 = Trizol extracts; * = No amplifica-
tion was achieved from FFPE) ΔCT = CT (no_PreAmp) - CT 
(with_PreAmp). The Theoretical ΔCT was 5.68 [= Log2(1024 
ng/20 ng)] which was calculated based on an input of 1024 ng 
of cDNA for the TaqMan® real time PCR component of pre-
amplification process and 20 ng of cDNA for the TaqMan® 
without pre-amplification. Ideally, ΔCT is in a range between 
Theoretical ΔCT +/- 1 which was achieved in this experiment 
indicating there is no bias in the PreAmp.BMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
Page 8 of 11
(page number not for citation purposes)
The TaqMan® PreAmp technique addresses the challenge
faced by researchers working with rare or precious sam-
ples, which only limited RNA could be extracted from, to
perform gene expression analyses using real-time QRT-
PCR. The simple process enables the user to perform uni-
form amplification from as little as one nanogram of
cDNA (which was used in this study) or alternatively con-
duct up to 200 real-time PCR reactions per pre-amplifica-
tion reaction without compromising the available sample
material. Our results demonstrated that TaqMan® PreAmp
overcame the difficulties usually caused by low yields of
RNA extraction from FFPE.
Influence of TaqMan® Master Mix and amplicon length
This study demonstrated that the sensitivity of TaqMan®
detection was influenced by choice of Master Mix and
amplicon length in assay design. We evaluated UPMM
and GEMM which showed similar sensitivity for short
amplicons (less than 90 bp), while GEMM displayed bet-
ter sensitivity for longer amplicons (over 100 bp) com-
pared with UPMM in parallel snap frozen and FFPE
extracts (Figure 5). This effect was dissipated when UPMM
was used after pre-amplification, possibly because of the
increased copy number of template available or because
of the composition of the PreAmp MasterMix which is
closer in components to GEMM than UPMM. Reagents
can have a significant effect on assay reproducibility [27]
due to some parameters such as different polymerases
sensitivity [28], primer binding efficiency and the concen-
tration of Mg2+ [29]. Karrer et al. described the Monte
Carlo effect using plant material suggesting that the PCR
reproducibility could be limited when the number of
available templates is low. Increased concentrations of
Mg2+ reduced PCR variation possibly by allowing a higher
proportion of annealed primers extended by the more
active polymerase [29].
Our data corroborated the observation that amplicon size
is crucial in designing assays to analyze gene expression
levels not only using FFPE extracts but also using RNAs
with high integrity [12,15]. Many researchers have found
that short amplicons generated lower CTs than longer
amplicons on analysis of the same gene in FFPE [30,31].
Data generated in this study evaluating snap frozen sam-
ples using two sizes of GAPDH (Figure 3) demonstrated
GAPDH-67 generated a reduction in CT by 2 – 3 cycles
over GAPDH-122 in both GEMM and PreAmp experi-
ments, demonstrating that smaller amplicons give more
consistent results [32].
In addition, we found CTs between FFPE and snap frozen
were closer for small amplicons than that for large ampli-
cons (Figure 7). For example, the analysis of GAPDH
using a target amplicon of 67 bp displayed CTs 1 – 2.5
cycles closer between FFPE and snap frozen than the same
experiment using the longer amplicon size of 122 bp. We
further measured the amplification efficiency associated
with these two sizes of GAPDH assays using a broad dilu-
tion range (5 Log10s) which showed closed efficiencies
with 99.98% for GAPDH-67 and 99.92% for GAPDH-122
(data not shown). This measurement eliminates non-spe-
cific amplification that could contribute to decreased
amplification efficiency of the true target. Therefore, it
seems reasonable to conclude that the shift of efficiency
detected from frozen to fixed material (Figure 7) is due to
degradation of RNA in FFPE, and logical to extrapolate
that the longer an amplicon is, the more likely its template
will be degraded in extracted RNA. As a general rule,
house-keeping genes or normalising assays should have
amplicon sizes that match the size of the target whose
expression is to be measured [3] and amplicons less than
100 bp should be employed in gene expression studies
using FFPE materials.
Conclusion
We evaluated the effect of modifying recommended
extraction protocols to reproducibly produce RNA that
may be successfully amplified using QRT-PCR. We have
found the TaqMan® PreAmp system to be a robust and
practical solution to limited quantities of RNA and have
demonstrated comparable results in matched FFPE and
snap frozen preparations providing proof of principle that
this method may reliably be utilised in the context of mul-
tiple expression analyses from individual FFPE samples.
Methods
Cell culture and formalin fixation
Nthy-ori 3-1 (ECACC, Wiltshire, UK) is a normal thyroid
follicular epithelial cell line derived from adult thyroid tis-
sue that has been transfected with a plasmid encoding for
the SV40 large T gene [33].
This cell line was grown to confluence in a humidified
atmosphere containing 5% CO2 at 37°C in the following
plating medium: RPMI 1640 with 2 mM L-glutamine,
10% Foetal calf serum (FCS), Penicillin (100 U/ml) and
Streptomycin (100 μg/ml). Tripsinized cells were counted
with a hemocytometer. Approximately 1 × 105 suspended
cells were aliquot and were pelleted (a) snap frozen and
(b) formalin fixed and paraffin embedded into a cell
block. When formalin fixation was required, a cohesive
solid cell pellet was constructed using 20% agar [23]. The
cells were centrifuged in an eppendorf tube, and the
supernatant was removed using a pipette. Approximately
30 μl of pre-warmed agar (60°C) was added to each tube.
The solid cell pellet was formed within a few seconds. Cell
blocks were placed in 10% buffered formalin at room
temperature for 5 hours followed by tissue processing on
a Tissue-Tek® V.I.P.TM tissue processor for 8 hours com-
prising: 10% buffered formalin fixation (4 hours atBMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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37°C), 60% ethanol (20 minutes at 37°C), 80% ethanol
(20 minutes at 37°C), 100% ethanol (20 minutes at
37°C), xylene (40 minutes at 37°C) and paraffin (80
minutes at 60°C). The pellets were subsequently paraffin
embedded.
RNA extraction protocols
RNA extraction was performed using 4 protocols (Table
2): Ambion RecoverAll™ Total Nucleic Acid Isolation Kit,
Stratagene Absolutely RNA® FFPE Kit, Gentra Purescript®
RNA Purification Kit, and Invitrogen Trizol® Reagent, in
addition to modified Stratagene and Ambion protocols.
Apart from deparaffinazition, RNA was extracted from
snap frozen and FFPE cells in parallel according to manu-
facturer's protocols including proteinase K digestion (not
included in Trizol® protocol), RNA isolation and elution
or hydration procedures. The modification in Stratagene
and Ambion protocols involved incubation at 70°C for
20 minutes after the recommended proteinase K diges-
tion.
RNA quantity was assessed using the NanoDrop® ND-
1000 Spectrophotometer (Wilmington, USA), and the
quality was measured using the RNA 6000 Pico LabChip®
Kit on an Agilent 2100 Bioanalyser (Agilent technologies,
Waldbronn, Germany).
TaqMan® gene expression assays
Seven TaqMan® Gene Expression Assays (P/N: 4331182,
Applied Biosystems, CA, USA) and one custom designed
assay (GAPDH-67) were utilised in this study with a range
of amplicon sizes from 62 to 164 (Table 3). The extracted
RNA was reverse transcribed into cDNA and were then
quantified using TaqMan® real time PCR with or without
PreAmp procedure.
Table 3: Eight of TaqMan® Gene Expression Assays. Seven of these assays were inventoried by Applied Biosystems (P/N: 4331182, 
Applied Biosystems, CA, USA) and one was a designed assay (GAPDH-67 Forward primer: CAT CCA TGA CAA CTT TGG TAT 
CGT; Reverse primer: GGG TGG CAG TGA TGG CAT; Probe: ACT CAT GAC CAC AGT CC).
Gene Symbol – Amplicon Length Gene Name Assay ID
MT4 – 62 metallothionein IV Hs00262914_m1
GAPDH – 67 glyceraldehyde-3-phosphate dehydrogenase Designed
CDKN1B – 71 cyclin-dependent kinase inhibitor 1B (p27, Kip1) Hs00153277_m1
MAPK4 – 72 mitogen-activated protein kinase 4 Hs00177074_m1
CD44 – 86 CD44 molecule (Indian blood group) Hs00153304_m1
SDC2 – 103 syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan) Hs00299807_m1
GAPDH – 122 glyceraldehyde-3-phosphate dehydrogenase Hs99999905_m1
HLA-A – 164 major histocompatibility complex, class I, A Hs00740413_g1
Table 2: Overview of the RNA extraction protocols. Four RNA extraction protocols are Ambion RecoverAll™ Total Nucleic Acid 
Isolation Kit, Stratagene Absolutely RNA® FFPE Kit, Gentra Purescript® RNA Purification Kit and Invitrogen Trizol® Reagent. (RT. = 
Room temperature)
Ambion Stratagene Gentra Trizol
De-paraffiniztion Xylene
50°C for 3 min
Ethanol washes
Deparaffin – Reagent
RT. for 10 min
Ethanol washes
Xylene
RT. for 5 min
Ethanol washes
Xylene




4 μl Protease in 400 μl 
digestion buffer (final 
concentration unknown)
50°C for 3 hours
10 μl × 20 mg/ml proteinaseK 
in 100 μl digestion buffer (final 
concentration 1.82 μg/ul)
55°C overnight
1.5 μl × 20 mg/ml 
proteinaseK in 300 μl cell 




RNA isolation Add Isolation Additive
Add Ethanol






Pass the mixture through a 
prefilter spin cup
Add Ethanol








Add Isopropanol and 
Glycogen
-20°C for 1 hour
Pellet RNA and Ethanol wash
Homogenize in 1 ml Trizol 
Reagent
Add Chloroform
Separate the aqueous phase
Add Isopropanol and 
Glycogen
RT. for 10 min
Pellet RNA and Ethanol wash
RNA collection Elution buffer 30 μl × 2 Elution buffer 30 μl RNA hydration solution 30 μlH 2O 30 μlBMC Biotechnology 2008, 8:10 http://www.biomedcentral.com/1472-6750/8/10
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Reverse transcription (RT)
Applied Biosystems High-Capacity cDNA Archive Kit (P/
N: 4322171, Applied Biosystems) was used following
manufacturer's protocol for reverse transcription. Each RT
reaction contained 50 μl of 8 ng/μl total RNA, 10 μl of 10×
RT buffer, 4 μl of 25× dNTP mixture, 10 μl of 10× Random
Primers, 5 μl of MultiScribe RT (50 U/μl) and 21 μl of
RNase-free water. The 100 μl reactions were incubated in
an Applied Biosystems Thermocycler for 10 min at 25°C,
2 hours at 37°C and then held at 4°C.
TaqMan® real time PCR
For the Real-time PCR step, amplification was carried out
on the Applied Biosystems 7000 Sequence Detection Sys-
tem. Two types of TaqMan® Master Mix were employed in
this procedure: TaqMan® Universal PCR Master Mix with
UNG (P/N 4304437, Applied Biosystems) or TaqMan®
Gene Expression Master Mix (P/N 4370048, Applied Bio-
systems). The 20 μl PCR reaction included 10 μl of 2×
TaqMan® Master Mix, 5 μl of 4× TaqMan® Gene expression
Assay (P/N 4331182, Applied Biosystems) and 5 μl of
cDNA (RT product 4 ng/μl). The reactions were incubated
in a 96-well optical plate at 50°C for 2 min, at 95°C for
10 min, following by 40 cycles of 95°C for 15 seconds
and 60°C for 1 min. The real-time PCRs for each assay
were run in triplicate.
TaqMan® real time PCR with PreAmp
The preamplification was performed using TaqMan®
PreAmp Master Mix Kit protocol (P/N 4366128, Applied
Biosystems). The pooled assay mix was prepared by com-
bining 8 of 20× TaqMan® Gene Expression Assays into a
single tube and using 1× TE buffer to dilute the pooled
assays to a final concentration of 0.2×. The 40 μl of pream-
plification reaction included 20 μl of 2× TaqMan® PreAmp
Master Mix, 10 μl of 0.2× pooled assay mix and 10 μl of 4
ng/μl cDNA sample. The reactions were incubated in an
Applied Biosystems Thermocycler for 10 min at 95°C fol-
lowing by 10 cycles of 95°C for 15 seconds and 60°C for
4 min and then held at 4°C. The concentration of the
preamplification product was 210 ng/μl (in theory) which
was then 1:5 diluted and analyzed by TaqMan® real time
PCR using TaqMan® Universal PCR Master Mix following
the procedures described.
Data analysis
Replicates were omitted if CT  standard deviation was
greater than 1.5 in the triplicate. All the data were col-
lected in Excel form. The formulas used to generate the fig-
ures are as below:
1. ΔCT (A-B) = CT X_mean(A) - CT X_mean(B)
2. Theoretical ΔCT = Log2(Amount cDNA in A/Amount of
cDNA in B)
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